Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models
To facilitate the translation of immunotherapies from bench to bedside, predictive preclinical models are essential. We developed the in vivo immuno-oncology Hollow Fiber Assay (HFA) to bridge the gap between simpler cell-based in vitro assays and more complex mouse models for immuno-oncology drug e...
Saved in:
| Main Authors: | Tove Selvin, Malin Berglund, Anders Åkerström, Marco Zia, Jakob Rudfeldt, Malin Jarvius, Rolf Larsson, Claes R Andersson, Mårten Fryknäs |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | SLAS Technology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2472630324001146 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prophylactic evaluation of verubecestat on disease‐ and symptom‐modifying effects in 5XFAD mice
by: Adrian L. Oblak, et al.
Published: (2022-01-01) -
Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling
by: Cordelia Dunai, et al.
Published: (2025-01-01) -
Analysis of a cancer dormancy model and control of immuno-therapy
by: Ben Sheller, et al.
Published: (2015-05-01) -
Poor efficacy of the combination of clarithromycin, amikacin, and cefoxitin against Mycobacterium abscessus in the hollow fiber infection model
by: Etienne Vignaud, et al.
Published: (2025-01-01) -
Schimke immuno-osseous dysplasia in a boy with generalized edema; a case report
by: Paniz Pourpashang, et al.
Published: (2024-08-01)